BioRem Inc.
BIRMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $48 | $16 | $14 | $29 |
| - Cash | $5 | $2 | $4 | $4 |
| + Debt | $4 | $4 | $5 | $6 |
| Enterprise Value | $47 | $18 | $15 | $30 |
| Revenue | $37 | $25 | $29 | $24 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Gross Profit | $10 | $7 | $9 | $6 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| EBITDA | $5 | $3 | $3 | $3 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |
| Net Income | $3 | $2 | $2 | $1 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| % Growth | 23.1% | 41.5% | 164.8% | – |
| Operating Cash Flow | $4 | $0 | $1 | $4 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | $3 | -$0 | $1 | $4 |